A retrospective cohort study of 200 TP53 PV carriers found a 30-year cumulative probability of second cancers of 57%, and similar to the findings in our cohort, 30% of individuals with multiple cancers were diagnosed with a second breast cancer (9/30) [13]. This evidence concerns the gene TP53 and breast carcinoma.